Since the inception of this PPG 17 years ago, the goal of Core A has remained constant: to maximize the scientific progress and productivity of each project by providing responsive and effective centralized support services. The services provided fall under the following categories: Administrative, Statistical, and Research Personnel for Clinical Studies. The objectives of Core A are to provide all PPG projects and Core B with: 1) the leadership, oversight, and administrative support essential to maximize program performance; 2) the statistical support required to plan, conduct, and analyze data for all PPG studies;and 3) the personnel support necessary to successfully conduct and complete all PPG clinical studies. Core A achieves these objectives by coordinating the use of resources, services, and personnel. We foresee and have prepared for new scientific/medical challenges and opportunities in our renewal as we: 1) expand our focus to include a new but related research interest - neonatal thrombocytopenia - to provide critically needed information about this common problem responsible for significant morbidity and health care costs; 2) add two new performance sites - Children's Hospital Boston, and the University of Minnesota Children's Hospital - to draw on the expertise of physician-scientists performing research at these sites that is directly related to our PPG;and 3) add four new investigators and seven new consultants, with most located at the new sites and others at Emory University, the University of Cincinnati and the State University of New York at Buffalo. The logistical challenges presented by the increase in complexity associated with our renewal are offset by enhanced opportunities for outstanding team-driven scientific progress and productivity. In the section """"""""/. Overview of Core A, we list the new and continuing program investigators and consultants;in section """"""""//. Detailed description of Core A components,"""""""" we describe in detail the multifaceted structural approach that we have developed over the past 18 months to coordinate the activities and facilitate information exchange among investigators and staff dispersed across multiple performance sites.

Public Health Relevance

Anemia and thrombocytopenia are the two most common life-threatening and costly hematological problems encountered in NICUs throughout the US. Indeed, from a public-health standpoint, severe, transfusion-dependent anemia and thrombocytopenia remain expensive health-care problems with significant and costly short- and long-term adverse outcomes and health burdens. In supporting all 4 projects of this PPG, Core A contributes significantly to the development of the definitive, scientific evidence-based guidelines that will be needed for improved management of these two conditions.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Iowa
Iowa City
United States
Zip Code
Patel, Ravi M; Josephson, Cassandra D; Shenvi, Neeta et al. (2018) Platelet transfusions and mortality in necrotizing enterocolitis. Transfusion :
Teramo, Kari A; Klemetti, Miira M; Widness, John A (2018) Robust increases in erythropoietin production by the hypoxic fetus is a response to protect the brain and other vital organs. Pediatr Res :
Cakir, Bertan; Liegl, Raffael; Hellgren, Gunnel et al. (2018) Thrombocytopenia is associated with severe retinopathy of prematurity. JCI Insight 3:
Nalbant, Demet; Cancelas, José A; Mock, Donald M et al. (2018) In premature infants there is no decrease in 24-hour posttransfusion allogeneic red blood cell recovery after 42 days of storage. Transfusion 58:352-358
Benavides, Amanda; Metzger, Andrew; Tereshchenko, Alexander et al. (2018) Sex-specific alterations in preterm brain. Pediatr Res :
Mock, Donald M; Nalbant, Demet; Kyosseva, Svetlana V et al. (2018) Development, validation, and potential applications of biotinylated red blood cells for posttransfusion kinetics and other physiological studies: evidenced-based analysis and recommendations. Transfusion 58:2068-2081
Sparger, Katherine A; Ramsey, Haley; Lorenz, Viola et al. (2018) Developmental differences between newborn and adult mice in response to romiplostim. Platelets 29:365-372
MacQueen, B C; Christensen, R D; Henry, E et al. (2017) The immature platelet fraction: creating neonatal reference intervals and using these to categorize neonatal thrombocytopenias. J Perinatol 37:834-838
Schmidt, Robert L; Mock, Donald M; Franco, Robert S et al. (2017) Antibodies to biotinylated red blood cells in adults and infants: improved detection, partial characterization, and dependence on red blood cell-biotin dose. Transfusion 57:1488-1496
Wallin, Diana J; Zamora, Tara G; Alexander, Michelle et al. (2017) Neonatal mouse hippocampus: phlebotomy-induced anemia diminishes and treatment with erythropoietin partially rescues mammalian target of rapamycin signaling. Pediatr Res 82:501-508

Showing the most recent 10 out of 197 publications